Esperion Therapeutics shares are trading higher after the company announced that it entered into a Royalty Purchase Agreement with OMERS Life Sciences.
Esperion Therapeutics, Inc. +1.43% Pre
Esperion Therapeutics, Inc. ESPR | 2.13 2.16 | +1.43% +1.41% Pre |
Esperion Therapeutics shares are trading higher after the company announced that it entered into a Royalty Purchase Agreement with OMERS Life Sciences.